- Service category
- Analytical laboratory and testing services
Your company? Get access to this profile.
- Analytical service / development / validation
- Diagnostics service
- Plasmid DNA service
- Project management
- Report writing
- Sequencing services
- Synthesis services
Business Unit ‘Pharma Services'
Eurofins Medigenomix is your professional partner in pharmacogenetics and pharmacogenomics. Here we offer a comprehensive service portfolio for the entire drug development process – from preclinical research to clinical phase III trials. We aim for best service to fulfil your needs and requirements, flexible, fast and reliable – today and in the future.
We develop solutions tailored to your needs and take over comprehensive tasks in the areas of analysis, contract research and development. You profit from our flexibility in the disposition of capacities to meet your demands.
We provide you with competent and comprehensive advice to find the best solution for each project in planning at any time.
We vouch for highest quality with automated analytical methods, high capacities as well as standardized and highly efficient process flows.
Eurofins Medigenomix has many years of extensive experience in the application of different methods and techniques in the field of genetic analysis which are crucial for the entire drug development process, starting from the preclinical phase through all phases of clinical trials (phases I, II and III).
Eurofins Medigenomix offers a broad spectrum of services in the areas of analysis, research and development. We offer our services for single samples as well as for batches of few to several thousand samples on high throughput level. We attach great importance to well-founded scientific consultancy prior to and during all projects and studies.
With our services we help you to develop agents and drugs more efficiently and economically, to use them optimally and precisely regarding their effectiveness and last, but not least, to better avoid possible adverse effects.
Our pharma services portfolio includes, among other things, the following services:
- GLP-compliant genotyping and sequencing
- SNP, mutation- and biomarker analysis
- Analysis of target genes
- Expression analysis
- Residual DNA Testing
- Assay development and validation
- Scientific consultancy during the planning and implementation of analyses in the scope of clinical trials
- Expert advice on the evaluation and interpretation of results
- GLP-grade documentation (study plan and final report)
- Project consultancy and project management
Eurofins Medigenomix completes its comprehensive pharma services portfolio through addition of versatile services in the following key areas:
- Genomics: Sequencing of complete genomes, metagenomic analysis, re-sequencing of individual areas of defined genes, ultra-deep sequencing on amplicon level and transcriptome analysis / expression profiling using "Next Generation Sequencing" platforms
- Virus and microbiological diagnostics: Virus load determination, genotyping, sequencing and quantitative analyses of viruses and bacteria
- Gene Synthesis
Approvals, Certificates, Authorisations
- ISO EN 9001:2008
- ISO 17025:2005
You might be also interested in
Sourcing this company's services?Send inquiry anonymously »